Gilder Gagnon Howe & CO LLC Olink Holding Ab (Publ) Transaction History

Gilder Gagnon Howe & CO LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$14.29 - $25.95 $5.84 Million - $10.6 Million	-408,591 Reduced 90.06%	45,109 $1.13 Million
Q3 2023 Nov 14, 2023	SELL	$14.45 - $20.34 $504,420 - $710,028	-34,908 Reduced 7.14%	453,700 $6.69 Million
Q2 2023 Aug 14, 2023	BUY	$17.13 - $23.74 $842,025 - $1.17 Million	49,155 Added 11.19%	488,608 $9.16 Million
Q1 2023 May 15, 2023	BUY	$19.34 - $24.11 $7.03 Million - $8.77 Million	363,680 Added 479.96%	439,453 $9.9 Million
Q4 2022 Feb 14, 2023	BUY	$12.64 - $25.52 $23,876 - $48,207	1,889 Added 2.56%	75,773 $1.92 Million
Q3 2022 Nov 14, 2022	SELL	$12.14 - $18.42 $6,859 - $10,407	-565 Reduced 0.76%	73,884 $897,000
Q2 2022 Aug 15, 2022	BUY	$8.95 - $19.24 $1,270 - $2,732	142 Added 0.19%	74,449 $1.13 Million
Q1 2022 May 16, 2022	BUY	$11.33 - $19.3 $261,496 - $445,444	23,080 Added 45.05%	74,307 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$18.0 - $34.82 $305,982 - $591,905	16,999 Added 49.66%	51,227 $932,000
Q3 2021 Nov 15, 2021	BUY	$23.42 - $37.93 $52,929 - $85,721	2,260 Added 7.07%	34,228 $830,000
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $851,947 - $1.26 Million	31,968 New	31,968 $1.1 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.